Safety of Intracoronary Administration of c-myc Antisense Oligomers After Percutaneous Transluminal Coronary Angioplasty (PTCA)

Author:

Roqué Fernando1,Mon Guillermo1,Belardi Jorge2,Rodriguez Alfredo3,Grinfeld Liliana1,Long Robert4,Grossman Steven4,Malcolm Alasdair5,Zon Gerald6,Ormont Michael L.7,Fischman David L.7,Shi Yi7,Zalewski Andrew7

Affiliation:

1. Clinica Olivos, Buenos Aires, Republica Argentina

2. Instituto Cardiovascular de Buenos Aires, Republica Argentina

3. Sanatorio Anchorena, Buenos Aires, Republica Argentina

4. Glaxo Wellcome, Inc., Research Triangle Park, NC

5. Glaxo Wellcome, PLU, UK

6. Lynx Therapeutics, Inc., Hayward, CA

7. Thomas Jefferson University, Philadelphia, PA

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology,Genetics

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Antisense molecules: A new class of drugs;Journal of Allergy and Clinical Immunology;2016-05

2. Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma;Cancer Gene Therapy;2010-12-24

3. Antisense strategies in degenerative joint diseases: Sense or nonsense?☆;Advanced Drug Delivery Reviews;2006-05-20

4. Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide;Current Pharmaceutical Biotechnology;2006-04-01

5. Cytostatic gene therapy for occlusive vascular disease;Expert Opinion on Therapeutic Patents;2006-03-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3